跳至主要内容
临床试验/EUCTR2014-004682-24-ES
EUCTR2014-004682-24-ES进行中(未招募)1 期

Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prospective, multicenter, randomised, double-blind, placebo controlled study in parallel groups

PIERRE FABRE MEDICAMENT0 个研究点目标入组 414 人开始时间: 2015年11月10日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
414

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Male or female, over 18 years old
  • - Subject needing to undergo extraction of one impacted mandibular third molar
  • - For woman of childbearing potential and for woman in menopausal period under hormonal substitution treatment, she must accept to plan the extraction of the impacted mandibular third molar only during the last week of the menstrual cycle
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 374
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Existence or history of parotid gland disorders
  • - Acute or history of recent acute pericoronitis at any tooth
  • - Extraction of more than 1 third molar in the same surgical procedure
  • - Subject at high risk of bacterial endocarditis (prosthetic heart valve, history of bacterial endocarditis, congenital cyanogenic heart disease)
  • - Coagulation or haemostatic disorder or use of anticoagulants
  • - Hypersensitivity to chlorhexidine or any of the excipients;
  • - Hypersensitivity to any anesthetic agent;
  • - Hypersensitivity to corticosteroids, analgesics including opioid drugs used for post-surgery pain relief
  • - Intake of systemic vasodilator or vasoconstrictor
  • - Intake of systemic or local (in the mouth) antibiotics within 7 days before Day 1 and/or any pre- or post-operative antibiotic prophylaxis planned to be prescribed during the study;
  • - Use of any antiseptic mouthwash within 7 days before Day -1
  • - Regular heavy smokers (more than 20 cigarettes per day)
  • - Is pregnant or in post-partum period or a nursing mother

研究者

相似试验

进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.0 Level: PT Classification code 10066995 Term: Alveolar osteitis System Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-FRPIERRE FABRE MEDICAMENT409
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.
EUCTR2014-004682-24-EEInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.1Level: PTClassification code 10066995Term: Alveolar osteitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-LTInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.
EUCTR2014-004682-24-LVInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414
已完成
4 期
Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar ExtractionAlveolar Osteitis
NCT02382809Pierre Fabre Medicament414